739029.fig.004a
(a) The overall discontinuation rate
739029.fig.004b
(b) The discontinuation rate of naïve CHC patients treated with the two types of peginterferons
739029.fig.004c
(c) Peginterferon dose modification of CHC patients treated with the two types of peginterferons
739029.fig.004d
(d) Ribavirin dose modification of CHC patients treated with the two types of peginterferons
Figure 4: The discontinuation rates and drugs modification of CHC patients who received the two regimens.